Private Equity

A new Verdantix report names Gravity the leader in sustainability software, as investors ditch estimates for granular data to drive financial returns.

EPA head Lee Zeldin and Nobel laureate John Clauser will lead a DC conference challenging the 'climate crisis,' raising the stakes in the policy debate.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

Award-winning design firm McKinley Architecture and Engineering deepens its 40-year Ohio presence, opening a new office led by local talent to drive growth.

Questel appoints Frederic Beylier as its new CEO, signaling a strategic shift towards AI and accelerated growth in the evolving intellectual property landscape.

The strategic acquisition of Certinet Systems expands Convergence Networks' regional footprint and deepens its cybersecurity prowess for regulated industries.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

ATI Physical Therapy returns to the McDonald's All American Games, providing elite medical care and championing local adaptive sports through a key grant.

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

A massive $4.8 billion unitranche deal fuels the creation of an e-commerce logistics giant, combining tech and transport to reshape the shipping industry.

SWBC's move to INTX's modern platform signals a major industry trend, replacing outdated systems to boost efficiency, governance, and scalability.

Bessor Minerals abruptly terminates its Jagrite Graphite Project deal, raising questions about its strategy and the volatile critical minerals market.

Health Canada greenlights MeMed's rapid diagnostic tool, a major step in the nation's fight against deadly sepsis and growing antimicrobial resistance.

With a massive new launch, Suave is directly challenging luxury brands by offering high-performance 'dupes' at a fraction of the cost. Is this the new normal?

Private equity firm Etna Capital has acquired AI specialist CodeRoad, a strategic move betting on agentic AI and Latin America's growing tech talent pool.

Biolojic Design's adaptive AI drug for asthma and eczema hits a key milestone with Teva, heralding a new era for personalized autoimmune treatment.

KNOT Offshore Partners' acquisition deal has been terminated, raising strategic questions. But a booming shuttle tanker market offers a powerful tailwind.

The man who built PetWise from the ground up is back in the driver's seat, signaling a major strategic shift focused on innovation and growth.

As funding expires for Wayne State's 35-year heart experiments on dogs, advocates and lawmakers urge the NIH to end a legacy of waste and suffering.